Surapol Issaragrisil
- Hematology top 0.2%
- Genetics top 0.2%
- Molecular Biology top 10%
- Rheumatology top 1%
- Oncology top 5%
- Co-authors
- Sudjit LuanpitpongTimothy P. HughesAndreas HochhausRichard A. LarsonGiuseppe SaglioHagop M. KantarjianRichard E. ClarkGabriel Étienne
- Topics
- Hematopoietic Stem Cell Transplantation (39 papers)Pluripotent Stem Cells Research (24 papers)Hippo pathway signaling and YAP/TAZ (18 papers)
- Cited by
- HematologyGeneticsRheumatology
- Journals
- New England Journal of MedicineSHILAP Revista de lepidopterologíaBlood
- Partner nations
- ThailandUnited StatesGermany
In The Last Decade
Surapol Issaragrisil
150 papers receiving 4.4k citations
Hit Papers
Peers
Comparison fields: 5 of 129
- Hematology 2.5k
- Genetics 1.9k
- Molecular Biology 991
- Rheumatology 863
- Oncology 733
Countries citing papers authored by Surapol Issaragrisil
This map shows the geographic impact of Surapol Issaragrisil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Surapol Issaragrisil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Surapol Issaragrisil more than expected).
Fields of papers citing papers by Surapol Issaragrisil
This network shows the impact of papers produced by Surapol Issaragrisil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Surapol Issaragrisil. The network helps show where Surapol Issaragrisil may publish in the future.
Co-authorship network of co-authors of Surapol Issaragrisil
This figure shows the co-authorship network connecting the top 25 collaborators of Surapol Issaragrisil. A scholar is included among the top collaborators of Surapol Issaragrisil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Surapol Issaragrisil. Surapol Issaragrisil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 6 | |
| 6 | 11 | |
| 7 | 8 | |
| 8 | 2 | |
| 9 | 34 | |
| 10 | 1 | |
| 11 | 3 | |
| 12 | 3 | |
| 13 | 40 | |
| 14 | Long-term benefits and risks of frontline nilotinib vs imatinib for chronic myeloid leukemia in chronic phase: 5-year update of the randomized ENESTnd trialbreakdown → | 563 |
| 15 | 10 | |
| 16 | 4 | |
| 17 | 3 | |
| 18 | Epidemiology of aplastic anemia in Thailand. Thai Aplastic Anemia Study Group. | 10 |
| 19 | 15 | |
| 20 | 3 |
About Surapol Issaragrisil
Surapol Issaragrisil is a scholar working on Hematology, Genetics and Transplantation, having authored 155 papers that have together received 4.5k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (39 papers), Pluripotent Stem Cells Research (24 papers) and Hippo pathway signaling and YAP/TAZ (18 papers). The work is most often cited by research in Hematology (2.5k citations), Genetics (1.9k citations) and Rheumatology (863 citations). Surapol Issaragrisil has collaborated with scholars based in Thailand, United States and Germany. Frequent co-authors include Sudjit Luanpitpong, Timothy P. Hughes, Andreas Hochhaus, Richard A. Larson, Giuseppe Saglio, Hagop M. Kantarjian, Richard E. Clark, Gabriel Étienne, Paweorn Angsutararux and Neil J. Gallagher. Their work appears in journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.